Skip Navigation LinksHome > November 2010 - Volume 34 - Issue 11 > Hybrid Myxoinflammatory Fibroblastic Sarcoma/Hemosiderotic F...
American Journal of Surgical Pathology:
doi: 10.1097/PAS.0b013e3181f17d51
Case Reports

Hybrid Myxoinflammatory Fibroblastic Sarcoma/Hemosiderotic Fibrolipomatous Tumor: Report of a Case Providing Further Evidence for a Pathogenetic Link

Elco, Christopher P. MD, PhD*; Mariño-Enríquez, Adrián MD* †; Abraham, John A. MD; Cin, Paola Dal PhD*; Hornick, Jason L. MD, PhD*

Collapse Box


Myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor are rare, slow-growing soft tissue tumors of the distal extremities with recurrent potential. Recent cytogenetic studies have shown a t(1;10)(p22;q24) or der(10)t(1;10) in combination with aberrations of chromosome 3 in a limited number of cases of both entities. Here we report a case of a 42-year-old female with a soft tissue tumor of the ankle showing hybrid morphologic features of myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor, a der(10)t(1;10), and abnormalities of chromosome 3. This hybrid lesion provides further evidence for a close relationship between these 2 tumor types.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.